导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -0.93% | 580/1050 |
| 近一周 | -1.78% | 314/1104 |
| 近一月 | -3.66% | 434/1102 |
| 近一季 | -7.69% | 563/1092 |
| 近半年 | -1.42% | 464/1070 |
| 近一年 | 1.90% | 539/1018 |
| 近两年 | 40.78% | 576/926 |
| 近三年 | 4.43% | 630/834 |
| 成立以来 | 41.60% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-3.26% 730/1070 |
10.42% 537/1101 |
- - |
- - |
| 2025 | 19.74% 675/1065 |
1.34% 696/1014 |
3.33% 409/1038 |
12.03% 806/1050 |
2.07% 300/1065 |
| 2024 | -15.44% 867/1011 |
-12.40% 835/960 |
-11.22% 894/983 |
11.72% 479/991 |
-2.68% 510/1011 |
| 2023 | -0.92% 115/952 |
5.33% 305/880 |
-2.57% 342/895 |
-6.60% 400/915 |
3.37% 40/952 |
| 2022 | -15.74% 195/867 |
-14.81% 252/773 |
6.46% 440/806 |
-9.50% 214/845 |
2.66% 291/867 |
| 2021 | -8.84% 477/740 |
-6.25% 392/580 |
10.20% 352/659 |
-6.18% 393/704 |
-5.96% 614/740 |
| 2020 | 35.10% 328/554 |
-0.54% 173/419 |
14.53% 362/466 |
12.60% 192/517 |
5.33% 432/554 |
| 2019 | 44.68% 187/410 |
26.41% 603/1149 |
-1.34% 473/1231 |
6.19% 177/390 |
9.24% 183/410 |
| 2018 | -19.86% 76/349 |
- - |
- - |
- - |
-12.82% 708/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 德邦量化优选股票(LOF)C VS. 东吴新产业精选股票A(580008) |